CatalYm raised $150m in Series D funding co-led by Canaan Partners and Bioqube Ventures

Biotech Health services Manufacturing

Investments

04 July 2024

CatalYm (company)

Biotech Health services Manufacturing

Total investments received (USD): 260.69m

Round value (USD): 150m

Round investors: Brandon Capital Partners Forbion Capital Partners Gilde Healthcare Jeito Capital Novartis Venture Fund Omega Funds Vesalius Biocapital Partners Canaan Partners Bioqube Ventures

Company: CatalYm

Industry: Biotech Health services Manufacturing

Health services Manufacturing Sports Industry

Investments 10 September 2024

Biotech Health services Pharma

Investments 01 June 2024

Biotech Health services Pharma

Secondary 21 March 2024

Biotech Health services

Investments 03 March 2024